Prototype LNP-mRNA vaccine candidates [SC_RNAseq]
Single-cell RNA-seq · mouse · 14 samples
- What it is
- Single-cell RNA-seqGene activity measured in thousands of individual cells, so cell types can be told apart. Read from the summary: GEO's own type field only says 'expression profiling by sequencing', so confirm it in the paper.
- Organism
- Mus musculus (mouse)
- Samples
- 14 samples: 4 × LNP-mRNA vaccine, panLow vs 4 × LNP-mRNA vaccine, panHigh vs 3 × LNP-mRNA vaccine, pbs vs 3 × LNP-mRNA vaccine, deltaGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE207141_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Single-cell studies usually ship their counts as 10x files (matrix.mtx, barcodes.tsv, features.tsv), an .h5 file, or an .rds / .h5ad object that Seurat or Scanpy can open. Look for those among the supplementary files.
Also filed as BioProject PRJNA853803 and SRA study SRP384059. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 14 samples.
How we read this: 4 replicated groups read from 14 sample titles; they account for 14 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM6280304 LNP-mRNA vaccine, pbs_6 LNP-mRNA vaccine, pbs
- GSM6280305 LNP-mRNA vaccine, pbs_7 LNP-mRNA vaccine, pbs
- GSM6280306 LNP-mRNA vaccine, pbs_8 LNP-mRNA vaccine, pbs
- GSM6280307 LNP-mRNA vaccine, delta_6 LNP-mRNA vaccine, delta
- GSM6280308 LNP-mRNA vaccine, delta_7 LNP-mRNA vaccine, delta
- GSM6280309 LNP-mRNA vaccine, delta_8 LNP-mRNA vaccine, delta
- GSM6280310 LNP-mRNA vaccine, panLow_6 LNP-mRNA vaccine, panLow
- GSM6280311 LNP-mRNA vaccine, panLow_7 LNP-mRNA vaccine, panLow
- GSM6280312 LNP-mRNA vaccine, panLow_8 LNP-mRNA vaccine, panLow
- GSM6280313 LNP-mRNA vaccine, panLow_9 LNP-mRNA vaccine, panLow
- GSM6280314 LNP-mRNA vaccine, panHigh_6 LNP-mRNA vaccine, panHi…
- GSM6280315 LNP-mRNA vaccine, panHigh_7 LNP-mRNA vaccine, panHi…
- GSM6280316 LNP-mRNA vaccine, panHigh_8 LNP-mRNA vaccine, panHi…
- GSM6280317 LNP-mRNA vaccine, panHigh_9 LNP-mRNA vaccine, panHi…
- GSE269493 Hepatoprotective effects of late-stage clinical drug candidates and dietary intervention in the non-obese CDAA-HFD mouse model of advanced MASH with progressive fibrosis 81 samples shares candidates
- GSE268241 HPV16-expressing tumors release multiple IL-1 ligands to orchestrate systemic immunosuppression whose disruption enables efficacy of a therapeutic vaccine. 63 samples shares vaccine
- GSE270151 Development of an ideal inactivated vaccine for COVID-19 (mouse lung RNA-seq data) 52 samples shares vaccine
- GSE270091 The Ddx21 mutant peptide is a potent neoantigen in preventive lung cancer vaccines and can activate long-term immune function 48 samples shares vaccine
- GSE325822 Bimodal Imaging-Guided Temporal Optimization of Combined Chemotherapy and DC Vaccine Immunotherapy 45 samples shares vaccine
- GSE230863 Therapeutic vaccine induced plasma cell differentiation is defective upon persistent HBsAg stimulation 45 samples shares vaccine
- GSE245436 The efficacy of LCMV-based cancer vaccines is unleashed by intratumoral injections of polyI:C 36 samples shares vaccine
- GSE246438 Novel lipid nanoparticle adjuvants vaccine for porcine reproductive and respiratory syndrome (PRRS) using in-vitro macrophage assays 36 samples shares vaccine
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.